Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
Phase 1
Recruiting
- Conditions
- Type 2 DiabetesOverweight or Obesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Carmot Australia First Pty Ltd
- Target Recruit Count
- 118
- Registration Number
- NCT05814107
- Locations
- 🇦🇺
Carmot Clinical Research Unit 101, Melbourne, Australia
© Copyright 2025. All Rights Reserved by MedPath